Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideIDXXIdexx Laboratories
FinDog View：Bullish
JNJJohnson & Johnson
FinDog View：Bullish
| Metric | IDXX | JNJ |
|---|
| Close | 551.21 | 273.20 |
| Market Cap | $43.9B | $666B |
| 1M | +5.56% | +3.20% |
| P/E (TTM) | 38.9 | 41.3 |
| Forward P/E | 32.2 | 22.0 |
| P/E 5-Yr Percentile | 7 | 100 |
| P/S | 9.8 | 6.7 |
| P/B | 27.5 | 7.8 |
| Dividend Yield | — | 3.12% |
| Latest Quarter Revenue | $1.2B | $25.4B |
| Revenue YoY | +9.7% | +5.9% |
| Gross Margin | 64.0% | 68.1% |
| Latest Quarter EPS | 4.27 | 0.09 |
| Avg Post-Earnings Move | ±1.8% | ±0.6% |
| EPS Beat Rate | — | 1 / 1 |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.68% | 1.18% |
| 90-Day Net Insider Buying | −$1.2M | −$62.0M |
IDXX · Revenue, Last 8 Quarters ($B)
JNJ · Revenue, Last 8 Quarters ($B)
